Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 2, 2007, Pages 205-210

  Reichel, Oliver ^a   Keller, Jeanette ^a   Rasp, Gerd ^b   Hagedorn, Hjalmar ^a   Berghaus, Alexander ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAFFEINE; ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; DIETARY INTAKE; DRUG EFFICACY; FEMALE; HUMAN; LARYNGOPHARYNGEAL REFLUX; LIFESTYLE MODIFICATION; MALE; PROSPECTIVE STUDY; SIDE EFFECT; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED, 80 AND OVER; ENZYME INHIBITORS; FEMALE; FUNDOPLICATION; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOPHARYNX; LIFE STYLE; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OMEPRAZOLE; PHARYNGEAL DISEASES;

EID: 33846639765     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.10.011     Document Type: Article

References (16)

1. Vincent Jr. D.A., Garrett D., Radionoff S.L., et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 14 (2000) 247-254 (Grade B)
2. Koufman J.A., Weiner G.J., Wallace C.W., et al. Reflux laryngitis and its sequelae. J Voice 2 (1988) 78-79 (Grade B)
3. Book D.T., Rhee J.S., Toohill R.J., et al. Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope 112 (2002) 1399-1406 (Grade B)
4. Koufman J.A., Aviv J.E., Casiano R.R., et al. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127 (2002) 32-35 (Grade D)
5. DelGaudio J.M., and Waring J.P. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 113 (2003) 598-601 (Grade A)
6. ®, adverse reactions. Available at: www.astra-zeneca.us.com. Accessed August 20, 2006.
7. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 suppl 53 (1991) 1-78 (Grade A)
8. Ylitalo R., Lindestad P., and Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 111 (2001) 1735-1741 (Grade A)
9. Knight J., Lively M.O., Johnston N., et al. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115 (2005) 1473-1478 (Grade A)
10. Chiverton S.G., Howden C.W., Burget D.W., et al. Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Aliment Pharmacol Ther 6 (1992) 103-111 (Grade A)
11. Kahrilas P.J., Falk G.W., Johnson D.A., et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther 14 (2000) 1249-1258 (Grade A)
12. Park W., Hicks D.M., Khandwala F., et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115 (2005) 1230-1238 (Grade A)
13. Laursen L.S., Bondesen S., Hansen J., et al. Omeprazole 20 mg or 40 mg for the treatment of gastroesophageal reflux disease? A double blind comparative study. Gastroenterology 102 (1992) A110 (Grade A)
14. Leite L.P., Johnston B.T., Just R.J., et al. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91 (1996) 1527-1531 (Grade B)
15. Amin M.R., Postma G.N., Johnson P., et al. Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. Otolaryngol Head Neck Surg 125 (2001) 374-378 (Grade B)
16. Belafsky P.C., Postma G.N., and Koufman J.A. Validity and reliability of the reflux symptom index (RSI). J Voice 16 (2002) 274-277 (Grade B)